Molecular basis of mast cell disease

被引:14
|
作者
Soucie, Erinn [1 ]
Brenet, Fabienne [1 ]
Dubreuil, Patrice [1 ]
机构
[1] Aix Marseille Univ UM 105, CNRS,UMR7258, Inst J Paoli I Calmettes, Inserm U1068,Ctr Reference Mastocytoses,Ctr Rech, Marseille, France
关键词
Mastocytosis; Mast cells; Mutations; Splicing; Epigenetic; TYROSINE KINASE INHIBITOR; EMBRYONIC STEM-CELLS; C-KIT MUTATION; SYSTEMIC MASTOCYTOSIS; SR PROTEINS; MYELODYSPLASTIC SYNDROMES; PEDIATRIC MASTOCYTOSIS; MYELOID MALIGNANCIES; DOMAIN MUTATIONS; GENE-EXPRESSION;
D O I
10.1016/j.molimm.2014.03.013
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Mastocytosis is an incurable and sometimes fatal haematological disorder grossly described as the accumulation of abnormal mast cells in the bone marrow and other organs causing tissue and organ damage. The clinical manifestations of this disease are extremely variable; disease phenotypes range from indolent to aggressive, and often present with associated non-mast cell haematological disorders (AHNMD), mainly myeloproliferative neoplasm and myelodysplastic syndromes. Recent efforts to genetically dissect the mechanisms that define aggressive and non-aggressive mastocytosis have generated a list of recurrent somatic mutations in mastocytosis patients that are associated with and may predict the evolution towards aggressive disease phenotypes. Here we review these mutations and discuss the molecular mechanisms associated with these mutations in an effort to better understand the biology of this disease and to predict its onset and evolution, with the ultimate goal of devising new and improved treatment strategies. (C) 2014 Elsevier Ltd. All rights reserved.
引用
收藏
页码:55 / 60
页数:6
相关论文
共 50 条
  • [1] The genetic basis of mast cell activation disease - looking through a glass darkly
    Molderings, Gerhard J.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2015, 93 (02) : 75 - 89
  • [2] THE MAST-CELL AND MAST-CELL DISEASE
    LONGLEY, J
    DUFFY, TP
    KOHN, S
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1995, 32 (04) : 545 - 561
  • [3] MOLECULAR-BASIS FOR STORAGE AND RELEASE OF HISTAMINE IN RAT MAST-CELL GRANULES
    UVNAS, B
    LIFE SCIENCES, 1974, 14 (12) : 2355 - 2366
  • [4] The molecular basis for the prothrombotic state in sickle cell disease
    Shet, Arun S.
    Lizarralde-Iragorri, Maria A.
    Naik, Rakhi P.
    HAEMATOLOGICA, 2020, 105 (10) : 2368 - 2379
  • [5] MAST CELL DISEASE
    RABINOVICH, S
    LEY, DCH
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 1963, 89 (15) : 770 - +
  • [6] Mast cell disease
    Schneider, I
    Schwartz, RA
    CUTIS, 1997, 59 (02): : 63 - 66
  • [7] MAST CELL DISEASE
    SIROIS, J
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 1963, 89 (20) : 1043 - &
  • [8] MAST CELL DISEASE
    MCBRIDE, TI
    DUGUID, WP
    MCDONALD, GA
    POSTGRADUATE MEDICAL JOURNAL, 1967, 43 (497) : 176 - &
  • [9] Monoclonal IgE antibodies and recombinant allergens: a basis for a molecular defined model of mast cell activation
    Hoffmann, A
    Kaul, S
    Danz, N
    Foetisch, K
    Karamloo, F
    Haustein, D
    Reese, G
    Vieths, S
    ALLERGY, 2002, 57 : 11 - 11
  • [10] MOLECULAR BASIS OF DISEASE
    JANEWAY, CA
    ACTA PAEDIATRICA SCANDINAVICA, 1962, 51 (01): : 99 - &